Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Cell Rep Med ; 2(5): 100241, 2021 05 18.
Article in English | MEDLINE | ID: mdl-34095872

ABSTRACT

Although the knee joint and temporomandibular joint (TMJ) experience similar incidence of cartilage ailments, the knee orthopedics field has greater funding and more effective end-stage treatment options. Translational research has resulted in the development of tissue-engineered products for knee cartilage repair, but the same is not true for TMJ cartilages. Here, we examine the anatomy and pathology of the joints, compare current treatments and products for cartilage afflictions, and explore ways to accelerate the TMJ field. We examine disparities, such as a 6-fold higher article count and 2,000-fold higher total joint replacement frequency in the knee compared to the TMJ, despite similarities in osteoarthritis incidence. Using knee orthopedics as a template, basic and translational research will drive the development and implementation of clinical products for the TMJ. With more funding opportunities, training programs, and federal guidance, millions of people afflicted with TMJ disorders could benefit from novel, life-changing therapeutics.


Subject(s)
Knee Joint/surgery , Osteoarthritis/surgery , Temporomandibular Joint Disc/surgery , Temporomandibular Joint/surgery , Cartilage, Articular/pathology , Cartilage, Articular/surgery , Humans , Knee Joint/pathology , Osteoarthritis/pathology , Temporomandibular Joint/pathology , Temporomandibular Joint Disc/pathology , Temporomandibular Joint Disorders/pathology , Temporomandibular Joint Disorders/surgery
2.
J Oral Maxillofac Surg ; 76(9): 1930.e1-1930.e5, 2018 09.
Article in English | MEDLINE | ID: mdl-29458027

ABSTRACT

Mucormycosis, also known as zygomycosis, is an aggressive infection caused by a ubiquitous group of molds known as mucormycetes and is often associated with immune suppression or trauma among immunocompetent populations. We present the case of a 19-year-old woman who was involved in a motor vehicle accident in whom rapidly progressive invasive cutaneous facial mucormycosis subsequently developed. The diagnosis, treatment options, and incidence of this disease process are discussed in the context of trauma.


Subject(s)
Facial Injuries/microbiology , Mucormycosis/diagnosis , Accidents, Traffic , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Biomarkers/analysis , Combined Modality Therapy , Diagnosis, Differential , Facial Injuries/drug therapy , Facial Injuries/surgery , Fatal Outcome , Female , Humans , Mucormycosis/drug therapy , Mucormycosis/surgery , Young Adult
3.
J Biomed Mater Res B Appl Biomater ; 103(3): 529-38, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24934595

ABSTRACT

This study investigated the use of injectable poly(propylene fumarate) (PPF) formulations for mandibular fracture stabilization applications. A full factorial design with main effects analysis was employed to evaluate the effects of the PPF:N-vinyl pyrrolidone (NVP, crosslinking agent) ratio and dimethyl toluidine (DMT, accelerator) concentration on key physicochemical properties including setting time, maximum temperature, mechanical properties, sol fraction, and swelling ratio. Additionally, the effects of formulation crosslinking time on the mechanical and swelling properties were investigated. The results showed that increasing the PPF:NVP ratio from 3:1 to 4:1 or decreasing the DMT concentration from 0.05 to 0.01 v/w % significantly decreased all mechanical properties as well as significantly increased the sol fraction and swelling ratio. Also, increasing the crosslinking time at 37°C from 1 to 7 days significantly increased all mechanical properties and decreased both the sol fraction and swelling ratio. This study further showed that the flexural stiffness of ex vivo stabilized rabbit mandibles increased from 1.7 ± 0.3 N/mm with a traditional mini-plate fixator to 14.5 ± 4.1 N/mm for the 4:1 (0.05 v/w % DMT) PPF formulation at day 1. Overall, the formulations tested in this study were found to have properties suitable for potential further consideration in mandibular fracture fixation applications.


Subject(s)
Absorbable Implants , Biocompatible Materials/therapeutic use , Bone Cements/therapeutic use , Cementoplasty , Fumarates/therapeutic use , Mandibular Fractures/therapy , Polypropylenes/therapeutic use , Animals , Biocompatible Materials/administration & dosage , Bone Plates , Bone Screws , Compressive Strength , Cross-Linking Reagents/pharmacology , Fracture Fixation, Internal , Fumarates/administration & dosage , In Vitro Techniques , Injections, Intralesional , Mandibular Fractures/surgery , Materials Testing , Models, Anatomic , Pliability , Polymerization , Polypropylenes/administration & dosage , Pyrrolidinones/pharmacology , Rabbits , Stress, Mechanical , Temperature , Time Factors , Toluidines/pharmacology , Toluidines/therapeutic use , Torsion, Mechanical
4.
Bone ; 43(5): 931-40, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18675385

ABSTRACT

This study investigated the effects of dual delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2) for bone regeneration in a rat cranial critical size defect. Four groups of scaffolds were generated with VEGF (12 microg), BMP-2 (2 mug), both VEGF (12 microg) and BMP-2 (2 microg), or no growth factor released from gelatin microparticles incorporated within the scaffold pores. These scaffolds were implanted within an 8 mm rat cranial critical size defect (n=8-9 for each group). At 4 and 12 weeks, implants were retrieved and evaluated by microcomputed tomography (microCT) and histological scoring analysis. Additionally, 4 week animals were perfused with a radiopaque material to visualize and quantify blood vessel formation. Histological analysis revealed that for all groups at 4 weeks, a majority of the porous scaffold volume was filled with vascularized fibrous tissue; however, bone formation appeared most abundant in the dual release group at this time. At 12 weeks, both dual release and BMP-2 groups showed large amounts of bone formation within the scaffold pores and along the outer surfaces of the scaffold; osteoid secretion and mineralization were apparent, and new bone was often in close or direct contact with the scaffold interface. MicroCT results showed no significant difference among groups for blood vessel formation at 4 weeks (<4% blood vessel volume); however, the dual release group showed significantly higher bone formation (16.1+/-9.2% bone volume) than other groups at this time. At 12 weeks, dual release and BMP-2 groups exhibited significantly higher bone formation (39.7+/-14.1% and 37.4+/-18.8% bone volume, respectively) than either the VEGF group or blank scaffolds (6.3+/-4.8% and 7.8+/-7.1% bone volume, respectively). This work indicates a synergistic effect of the dual delivery of VEGF and BMP-2 on bone formation at 4 weeks and suggests an interplay between these growth factors for early bone regeneration. For the doses investigated, the results show that the addition of VEGF does not affect the amount of bone formation achieved by BMP-2 at 12 weeks; however, they also indicate that delivery of both growth factors may enhance bone bridging and union of the critical size defect compared to delivery of BMP-2 alone.


Subject(s)
Bone Morphogenetic Protein 2/metabolism , Drug Delivery Systems , Regeneration/physiology , Skull , Tissue Scaffolds , Vascular Endothelial Growth Factor A/metabolism , Animals , Bone Morphogenetic Protein 2/genetics , Gelatin/chemistry , Implants, Experimental , Male , Neovascularization, Physiologic , Particle Size , Rats , Rats, Inbred F344 , Skull/pathology , Skull/physiology , Tomography, X-Ray Computed , Vascular Endothelial Growth Factor A/genetics
6.
J Biomed Mater Res A ; 68(3): 428-38, 2004 Mar 01.
Article in English | MEDLINE | ID: mdl-14762922

ABSTRACT

In this work we sought to understand the effect of biomaterial properties upon healing bone tissue. We hypothesized that a hydrophilic polymer gel implanted into a bone tissue defect would impede the healing process owing to the biomaterial's prevention of protein adsorption and thus cell adhesion. To test this hypothesis, healing bone was investigated within a rabbit incisor extraction socket, a subcritical size bone defect that resists significant soft tissue invasion by virtue of its conformity. After removal of the incisor teeth, one tooth socket was left as an empty control, one was filled with crosslinked polymer networks formed from the hydrophobic polymer poly(propylene fumarate) (PPF), and one was filled with a hydrogel formed from the hydrophilic oligomer oligo(poly(ethylene glycol) fumarate) (OPF). At five different times (4 days as well as 1, 2, 4, and 8 weeks), jaw bone specimens containing the tooth sockets were removed. We analyzed bone healing by histomorphometrical analysis of hematoxylin and eosin stained sections as well as immunohistochemically stained sections. The proposed hypothesis, that a hydrophilic material would hinder bone healing, was supported by the histomorphometrical results. In addition, the immunohistochemical results reflect molecular signaling indicative of the early invasion of platelets, the vascularization of wound-healing tissue, the differentiation of migrating progenitor cells, and the formation and remodeling of bone tissue. Finally, the results emphasize the need to consider biomaterial properties and their differing effects upon endogenous growth factors, and thus bone healing, during the development of tissue engineering devices.


Subject(s)
Biocompatible Materials/pharmacology , Bone Regeneration/drug effects , Tooth Extraction , Tooth Socket/physiology , Animals , Fumarates , Growth Substances/analysis , Histocytochemistry , Hydrogel, Polyethylene Glycol Dimethacrylate , Hydrophobic and Hydrophilic Interactions , Models, Animal , Polyesters , Polyethylene Glycols , Polypropylenes , Rabbits
7.
Brain Res Bull ; 31(5): 553-63, 1993.
Article in English | MEDLINE | ID: mdl-8098654

ABSTRACT

Immunocytochemical methods were used to determine the distributions of glutamic acid decarboxylase (GAD), vasoactive intestinal polypeptide (VIP), cholecystokinin (CCK), and somatostatin (SOM) in the primary somatosensory cortex and somatosensory thalamus of adult raccoons. The cortex showed extensive immunoreactivity for GAD, revealing a large population of GABAergic neurons. GAD-labeled cells were numerous in all cortical layers, but were most concentrated in laminae II-IV. The cells were nonpyramidal and of varying morphology, typically with somata of small or medium size. GAD-immunoreactive puncta, presumably synaptic terminals, were widespread and often appeared to end on both GAD-negative and GAD-positive neurons. Immunoreactivity for the peptides was much less extensive than that for GAD, with the number of labeled neurons for VIP > CCK > SOM. Peptidergic cells were preferentially located in the upper and middle cortical layers, especially laminae II and III. The cells were nonpyramidal, often bitufted or bipolar in morphology, and small to medium in size. Their processes formed diffuse plexuses of fibers with terminal-like varicosities that occasionally surrounded nonpeptidergic neurons. The thalamus showed a clearly differentiated pattern of immunoreactivity for GAD, but little or no labeling for the three peptides. Nuclei adjoining the ventral posterior lateral (VPL)/ventral posterior medial (VPM) complex--including the reticular nucleus--contained many GAD-positive neurons and fibers. In contrast, the VPL and VPM nuclei displayed considerably less GAD immunoreactivity, somewhat surprising given the raccoon's highly developed somatosensory system. However, the ventral posterior inferior (VPI) nucleus revealed rather dense GAD labeling, perhaps related to a specialized role in sensory information processing. Thus, the primary somatosensory cortex of the raccoon showed patterns of immunoreactivity for GAD and peptides that were similar to those of other species; the somatosensory thalamus revealed a distinctive profile of GAD immunoreactivity, with labeling that was light to moderate in the VPL/VPM complex and relatively extensive in VPL.


Subject(s)
Glutamate Decarboxylase/metabolism , Neuropeptides/metabolism , Raccoons/metabolism , Somatosensory Cortex/metabolism , Thalamus/metabolism , Animals , Cholecystokinin/immunology , Cholecystokinin/metabolism , Glutamate Decarboxylase/immunology , Histocytochemistry , Immunoenzyme Techniques , Neuropeptides/immunology , Somatosensory Cortex/anatomy & histology , Somatosensory Cortex/immunology , Somatostatin/immunology , Somatostatin/metabolism , Thalamic Nuclei/anatomy & histology , Thalamic Nuclei/immunology , Thalamic Nuclei/metabolism , Thalamus/anatomy & histology , Thalamus/immunology , Vasoactive Intestinal Peptide/immunology , Vasoactive Intestinal Peptide/metabolism , gamma-Aminobutyric Acid/immunology , gamma-Aminobutyric Acid/metabolism
8.
Brain Res Bull ; 25(5): 787-90, 1990 Nov.
Article in English | MEDLINE | ID: mdl-1705158

ABSTRACT

The peroxidase-antiperoxidase method was used to examine major immunohistochemical features of the spinal cord of adult raccoons. The lateral portions of the ventral horn contained many large multipolar neurons that showed cholecystokinin-like immunoreactivity, suggesting the coexistence of cholecystokinin with acetylcholine in a subset of motoneurons. The dorsal horn revealed unique but overlapping patterns of immunoreactivity for glutamic acid decarboxylase, somatostatin, substance P, vasoactive intestinal polypeptide and cholecystokinin. The data imply that some of the peptides may coexist within the same dorsal root ganglion cells and their spinal cord processes.


Subject(s)
Glutamate Decarboxylase/analysis , Neuropeptides/analysis , Raccoons/metabolism , Spinal Cord/chemistry , Animals , Cholecystokinin/analysis , Choline O-Acetyltransferase/analysis , Immunohistochemistry , Somatostatin/analysis , Spinal Cord/enzymology , Substance P/analysis , Vasoactive Intestinal Peptide/analysis
9.
AJR Am J Roentgenol ; 150(1): 163-70, 1988 Jan.
Article in English | MEDLINE | ID: mdl-3257116

ABSTRACT

High-field-strength MR imaging was performed in one patient with Chiari III and 19 patients with Chiari II malformations. The MR features were compared with descriptions in the literature and correlated with previously described surgical and postmortem findings and with the results of previous radiologic investigations in this group of patients. Several new observations were apparent from the MR examinations. In 75% of the 20 cases, the underdeveloped tentorium with a wide incisura allowed inferior displacement of the medial posterior cerebrum, which appeared closely applied to a flattened aspect of the superior cerebellum. Previously reported CT descriptions of "pseudotumor of the tentorium" and "towering cerebellum" may be more related to the technique of the radiologic examination than to true upward herniation of the cerebellum. Elongation of the mesencephalon with increase in the mamillopontine distance was present in the majority of our cases and has not been previously emphasized. Some patients had atypical changes or appeared to be borderline cases between the Chiari I and Chiari II categories of malformation, and MR provided considerable diagnostic assistance in these cases. The noninvasive, in vivo evaluation of MR contributed a great deal to our further understanding of this congenital Chiari malformation.


Subject(s)
Arnold-Chiari Malformation/diagnosis , Brain/pathology , Magnetic Resonance Imaging , Spinal Cord/pathology , Adolescent , Adult , Arnold-Chiari Malformation/classification , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male
10.
AJR Am J Roentgenol ; 149(4): 807-13, 1987 Oct.
Article in English | MEDLINE | ID: mdl-3498334

ABSTRACT

An analysis of sagittal T1-weighted MR studies was performed in 23 patients with hydrocephalus, 58 patients with atrophy, and 100 normal patients. The average mamillopontine distance was 1.15 cm for the normal group, 1.2 cm for patients with atrophy, and 7.5 mm for patients with hydrocephalus. A reduction of the mamillopontine distance below 1.0 cm was found in 22 patients with hydrocephalus, 5 patients with atrophy, and 15 normal patients. Dilatation of the anterior third ventricle was noted in 21 patients in the hydrocephalus group and in none of the patients in the atrophy and normal groups. The average thickness of the corpus callosum at the level of the foramen of Monro was 6 mm in normal subjects and was reduced below 6 mm in 16 of the hydrocephalus patients. Smooth elevation of the corpus callosum was noted in 20 hydrocephalus patients, in 2 patients with atrophy, and in none of the normal patients. MR improves the accuracy of diagnosis in patients with hydrocephalus both because of its ability to show small obstructing lesions that are not depicted by CT and because the mass effect of the distended supratentorial ventricles produces anatomic changes that are delineated with precision by MR.


Subject(s)
Hydrocephalus/diagnosis , Magnetic Resonance Spectroscopy , Atrophy/diagnosis , Brain/pathology , Child , Child, Preschool , Female , Humans , Infant , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...